# MUC1 Vaccine in Conjunction With Poly-ICLC in Patients With Recurrent and/or Advanced Prostate Cancer

> **NCT00374049** · PHASE1 · COMPLETED · sponsor: **Olivera Finn** · enrollment: 14 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** MUC_1

## Key facts

- **NCT ID:** NCT00374049
- **Lead sponsor:** Olivera Finn
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-06
- **Primary completion:** 2008-01
- **Final completion:** 2015-12
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2016-07-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00374049

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00374049, "MUC1 Vaccine in Conjunction With Poly-ICLC in Patients With Recurrent and/or Advanced Prostate Cancer". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00374049. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*